Brief: Spero Therapeutics To Report First Quarter 2023 Financial Results On Thursday, May 11, 2023
04/05/2023 13:07
May 4 (Reuters) - Spero Therapeutics Inc SPRO.O :
* SPERO THERAPEUTICS TO PROVIDE BUSINESS UPDATE AND REPORT
FIRST
QUARTER 2023 FINANCIAL RESULTS ON THURSDAY, MAY 11, 2023
Source text for Eikon: ID:nGNXchcZ5b
Further company coverage: SPRO.O
Recent news on Spero Therapeutics
See all newsBrief: Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Spero Therapeutics - May Offer Up To $300 Million In Securities - SEC Filing
Brief: Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., As Chief Medical Officer
Spero licenses Innovent's experimental immune disease drug for up to $1.1 billion
US FDA approves GSK's oral antibiotic for drug-resistant UTIs (updated)